Back

Meta-analysis and predictors of cancer therapy-related right ventricular dysfunction: insights from FAC measurements

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology: new drugs, new challenges Diagnosis and Management of Cardiovascular Disease in Patients with Cancer ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Caroline Fischer Bacca

University Center for the Development of Alto Vale - UNIDAVI, Rio do Sul (Brazil)

6 More presentations in this session

Presentation thumbnail
The cardioprotective effect of inhibitor sodium glucose transporter in patients undergoing chemotherapy: a systematic review and meta-analysis
Mr J. Peres De Oliveira (BR)
Abstract Slides Video
Presentation thumbnail
Influence of the 3-omega fatty acids supplementation on the structure, regulation and vascular function of rats chronically treated with doxorubicin
Ms M. Gaiato Monte (Botucatu, BR)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes of TAVI in patients with active cancer: a bridge to success?
Doctor R. Carvalho (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis in cancer-related surgeries: a meta-analysis of efficacy and safety outcomes
Doctor K. Hosseini (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Ivabradine for prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis
Mr J. Peres De Oliveira (BR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardio-oncology: new drugs, new challenges

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Assessment of right ventricular dysfunction in breast cancer patients undergoing anthracycline and trastuzumab treatment
thumbnail
Congress Presentation
Longitudinal changes in right ventricular function in breast cancer patients undergoing cardiotoxic chemotherapy
thumbnail
Congress Presentation
3D echocardiography and biomarkers for early diagnosis and prediction of chemotherapy induced right ventricular dysfunction in non-Hodgkin lymphoma patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources